No results for ‘’
Bal Pharma Ltd
NSE: BALPHARMA BSE: 524824
₹108.16
(1.11%)
Tue, 29 Sept 2026, 00:07 am
Market Cap (in Cr)174.02
PE Ratio23.90
Dividend1.10
Health Technology
Pharmaceuticals: Major
24.5KBal Pharma Income Statement
No Result Found
| Particulars |
|---|
| Total revenue |
| Gross profit |
| Operating expenses (excl. COGS) |
| Selling/general/admin expenses, total |
| Research & development |
| Selling/general/admin expenses, other |
| Other operating expenses, total |
| Operating income |
| Non-operating income, total |
| Interest expense, net of interest capitalized |
| Interest capitalized |
| Non-operating income, excl. interest expenses |
| Non-operating interest income |
| Miscellaneous non-operating expense |
| Unusual income/expense |
| Pretax income |
| Taxes |
| Non-controlling/minority interest |
| After tax other income/expense |
| Net income before discontinued operations |
| Net income |
| Dilution adjustment |
| Preferred dividends |
| Diluted net income available to common stockholders |
| Basic earnings per share (Basic EPS) |
| Diluted earnings per share (Diluted EPS) |
| EBITDA |
| EBIT |
| Total operating expenses |
| Prepaid expenses |
| Deferred income, current |
| Capital and operating lease obligations |
| Operating lease liabilities |
| Deferred tax liabilities |
| Deferred income, non-current |
| Minority interest |
| Change in accrued expenses |
| Common dividends paid |
| Preferred dividends paid |